Anthem Biosciences Limited (NSE:ANTHEM)
810.00
+25.60 (3.26%)
Jul 31, 2026, 3:30 PM IST
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 455.74 billion as of July 31, 2026. Its market cap has increased by 5.30% in one year.
Market Cap
455.74B
Enterprise Value
446.89B
Revenue
20.07B
Ranking
n/a
PE Ratio
80.06
Stock Price
810.00
ChartMarket Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 455.74B, an increase of 11.11%. That is a compound annual growth rate of 10.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 455.74B | 24.56% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 688.86B |
| OneSource Specialty Pharma | 193.56B |
| Concord Biotech | 139.14B |
| Blue Jet Healthcare | 115.92B |
| Supriya Lifescience | 69.21B |
| Zota Health Care | 42.44B |
| Dishman Carbogen Amcis | 29.05B |
| Panacea Biotec | 25.39B |